A recent study over COVID-19 Vaccines in India have suggested that one dose of vaccine is enough to develop a good amount of antibodies in the recovered patients. In order to study patients, researchers have divided the group into two with COVID positive & other as negative. "The COVID + group had developed 1000 units of antibodies which is 10 times more than non-Covid-19 group," says researchers at AIG Hospital, Hyderabad.
Courtesy: Times of India
Chemical and Fertilizers minister DV Sadananda Gowda vented out his frustration when asked about the pertaining vaccine shortage in India. Talking to reporters on May 13, he said, "I want to ask you, if the court says tomorrow that you have to give this much (vaccine), if it has not been produced, should we hang ourselves?" He also discarded allegations of political motives and assured of improvement in the situation.
Serum Institute of India CEO Adar Poonawalla has stated that the vaccine shortage is likely to continue for the next few months. Currently, the company is producing 60-70 million doses of Covishield a month but eyeing to ramp up the capacity to 100 million doses per month by July. He stated that the production capacity was not upped earlier as authorities did not expect the second COVID-19 wave.
Courtesy: Times now news
Discarding the claims of COVID-19 vaccine shortage, Union Health Minister Harsh Vardhan on April 8 clarified that India has 43 million vaccine doses, either stocked or in supply pipeline. The clarification came days after several states, including Maharashtra, Odisha, Jharkhand, Andhra Pradesh and Rajasthan, claimed of vaccine shortage and likelihood of closure of vaccination centres. Calling for “an end to fear mongering", the minister said… read-more
Courtesy: Hindustan Times